Company

Alphamab Oncology

Headquarters: Suzhou, China

Employees: 366

CEO: Dr. Ting Xu Ph.D.

HKEX: 9966

Market Cap

HK$2.27 Billion

HKD as of July 1, 2024

US$290.4 Million

Market Cap History

Alphamab Oncology market capitalization over time

Evolution of Alphamab Oncology market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Alphamab Oncology

Detailed Description

Alphamab Oncology, a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of oncology biologics. Its product pipeline includes KN046, a bispecific monoclonal antibody (BsAb) immune checkpoint inhibitor, which is in pivotal Phase III clinical trials that targets clinically-validated immune checkpoints, including programmed death ligand 1 (PD-L1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4); and KN026, a next generation anti-human epidermal growth factor receptor 2 (HER2) BsAb that is in Phase II clinical trials for treating HER2-positive breast cancers and I/II clinical trial treatment of heavily pre-treated breast cancers, as well as Phase II clinical trial for HER2-positive solid tumors. The company's product pipeline also comprises KN019, a CTLA-4-based immunosuppressant fusion protein, which is in Phase II clinical trial with potential broad applications in both auto-immune diseases and oncology treatment-induced immune disorders; and KN035, an injectable PD-L1 inhibitor that has completed phase II pivotal clinical trials for deficient mismatch repair/microsatellite instability-high solid tumors, and is in Phase III pivotal trials for biliary tract cancer. The company was founded in 2008 and is headquartered in Suzhou, the People's Republic of China.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Alphamab Oncology has the following listings and related stock indices.


Stock: HKEX: 9966 wb_incandescent

Details

Headquarters:

Building C23

Rooms 401 and 501 No. 218 Xinghu Street Suzhou Industrial Park

Suzhou, 215024

China

Phone: 86 512 6285 0800